By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mirus Biosciences and Fugent have settled a lawsuit in which Mirus alleged Fugent infringed on a patent covering a method for gene transfer.

Fugent said in a statement today that the litigation was "resolved to Fugent's satisifaction and with no monetary compensation or other damages being paid by Fugent to Mirus." Mirus had asked for treble damages and attorney's fees in its complaint.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.